Which thyroid test spares more patients from the knife?
NCT ID NCT02681328
First seen Jan 06, 2026 · Last updated May 16, 2026 · Updated 22 times
Summary
This study compares two genetic tests (Afirma and ThyroSeq) for thyroid nodules that have unclear biopsy results. The goal is to see which test more accurately identifies benign nodules, so patients can avoid unnecessary surgery and maintain quality of life. About 328 adults with indeterminate thyroid nodules are participating.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jonsson Comprehensive Cancer Center at UCLA
Los Angeles, California, 90095-1781, United States
Conditions
Explore the condition pages connected to this study.